Comparison of high-performance thin layer chromatography/UV-densitometry and UV-derivative spectrophotometry for the determination of trimetazidine in pharmaceutical formulations

1. W. C. Stanley and M. Marzilli, Metabolic therapy in the treatment of ischaemic heart disease: The pharmacology of trimetazidine, Fundam. Clin. Pharmacol.17 (2003) 133–145; https://doi.org/10.1046/j.1472-8206.2003.00154.x10.1046/j.1472-8206.2003.00154.xSearch in Google Scholar

2. P. Chrusciel, J. Rysz and M. Banach, Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease, Drugs74 (2014) 971–980; https://doi.org/10.1007/s40265-014-0233-510.1007/s40265-014-0233-5Search in Google Scholar

3. European Medicines Agency, European Medicines Agency recommends restricting use of trimetazidine-containing medicines, EMA/CHMP/417861/2012; EMA, London 2012, https://www.ema.europa.eu/documents/press-release/european-medicines-agency-recommends-restricting-use-trimetazi-dine-containing-medicines_en.pdf; last access date August 31, 2018.Search in Google Scholar

4. Z. Liu, J. M. Chen, H. Huang, M. Kuznicki, S. Zheng, W. Sun, N. Quan, L. Wang, H. Yang, H. M. Guo, J. Li and J. Zhuang, The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway, Metabolism65 (2016) 122–130; https://doi.org/10.1016/j.metabol.2015.10.02210.1016/j.metabol.2015.10.022Search in Google Scholar

5. A. Onay-Besikci and S. A. Özkan, Trimetazidine revisited: A comprehensive review of the pharmacological effects and analytical techniques for the determination of trimetazidine, Cardiovasc. Ther.26 (2008) 147–165; https://doi.org/10.1111/j.1527-3466.2008.00043.x10.1111/j.1527-3466.2008.00043.xSearch in Google Scholar

6. T. K. Murthy, G. D. Sankar and S. R. Yarraguntla, Visible spectrophotometric methods for the determination of trimetazidine dihydrochloride in pharmaceutical formulations, Indian Drugs39 (2002) 230–233.Search in Google Scholar

7. A. A. Chiş, F. G. Gligor, G. Cormoş, E. Curea and M. Bojiţă, Spectrophotometric method for the determination of amorolfine, Farmacia58 (2010) 629–636.Search in Google Scholar

8. S. O. Thoppil, R. M. Cardoza and P. D. Amin, Stability indicating HPTLC determination of trimetazidine as bulk drug and in pharmaceutical formulations, J. Pharm. Biomed. Anal.25 (2001) 15–20; https://doi.org/10.1016/S0731-7085(00)00440-410.1016/S0731-7085(00)00440-4Search in Google Scholar

9. L. I. Bebawy, M. F. El Tarras and S. A. El Sabour, Determination of trimetazidine dihydrochloride in the presence of its acid-induced degradation products, J. AOAC Int.87 (2004) 827–833.10.1093/jaoac/87.4.827Search in Google Scholar

10. M. Gackowski, M. Koba and K. Mądra-Gackowska, Determination of lormetazepam in tablets using high-performance liquid chromatography, and derivative spectrophotometry methods, J. Planar Chromatogr. - Mod. TLC31 (2018) 235–242; https://doi.org/10.1556/1006.2018.31.3.910.1556/1006.2018.31.3.9Search in Google Scholar

11. M. Gackowski, M. Koba and S. Kruszewski, Comparison of UV- and derivative-spectrophotometric and HPTLC UV-densitometric methods for the determination of amrinone and milrinone in bulk drugs, Curr. Pharm. Anal.14 (2018) 1–8; https://doi.org/10.2174/157341291466618062714165910.2174/1573412914666180627141659Search in Google Scholar

12. AOAC International, Guidelines for Standard Method Performance Requirements (Appendix F), AOAC Off. Methods Anal; AOAC Int. 2016, http://www.eoma.aoac.org/app_f.pdf; https://doi.org/10.13140/RG.2.2.20883.89125, access date August 31, 2018.Search in Google Scholar

13. P. Rashmin, P. Mrunali, D. Nitin, D. Nidhi and P. Bharat, HPTLC method development and validation: Strategy to minimize methodological failures, J. Food Drug Anal.20 (2012) 794–804; https://doi.org/10.6227/jfda.2012200408Search in Google Scholar

14. M. Koba, K. Koba and T. Bączek, Determination of oxazepam in pharmaceutical formulation by HPTLC UV-densitometric and UV-derivative spectrophotometry methods, Anal. Lett.42 (2009) 1831–1843; https://doi.org/10.1080/0003271090306071910.1080/00032710903060719Search in Google Scholar

15. B. Spangenberg, Does the Kubelka-Munk theory describe TLC evaluations correctly?, J. Planar Chromatogr. – Mod. TLC19 (2006) 332–341; https://doi.org/10.1556/JPC.19.2006.5.110.1556/JPC.19.2006.5.1Search in Google Scholar